Sichuan Kelun-Biotech Biopharmaceutical Statistics

Total Valuation

Sichuan Kelun-Biotech Biopharmaceutical has a market cap or net worth of HKD 35.99 billion. The enterprise value is 32.93 billion.

Market Cap	35.99B
Enterprise Value	32.93B

Important Dates

The next estimated earnings date is Tuesday, November 19, 2024.

Earnings Date	Nov 19, 2024
Ex-Dividend Date	n/a

Share Statistics

Sichuan Kelun-Biotech Biopharmaceutical has 222.84 million shares outstanding. The number of shares has increased by 75.62% in one year.

Current Share Class	n/a
Shares Outstanding	222.84M
Shares Change (YoY)	+75.62%
Shares Change (QoQ)	+2.36%
Owned by Insiders (%)	2.56%
Owned by Institutions (%)	9.65%
Float	47.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.42
PB Ratio	10.44
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-164.23
EV / Sales	16.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-54.29

Financial Position

The company has a current ratio of 5.70, with a Debt / Equity ratio of 0.01.

Current Ratio	5.70
Quick Ratio	5.51
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-22.72

Financial Efficiency

Return on equity (ROE) is -17.35% and return on invested capital (ROIC) is -8.18%.

Return on Equity (ROE)	-17.35%
Return on Assets (ROA)	-3.59%
Return on Capital (ROIC)	-8.18%
Revenue Per Employee	1.31M
Profits Per Employee	-130,031
Employee Count	1,477
Asset Turnover	0.59
Inventory Turnover	9.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +92.49% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+92.49%
50-Day Moving Average	181.96
200-Day Moving Average	155.10
Relative Strength Index (RSI)	35.05
Average Volume (20 Days)	280,762

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sichuan Kelun-Biotech Biopharmaceutical had revenue of HKD 2.02 billion and -200.51 million in losses. Loss per share was -0.92.

Revenue	2.02B
Gross Profit	1.25B
Operating Income	-197.32M
Pretax Income	-107.15M
Net Income	-200.51M
EBITDA	-153.00M
EBIT	-197.32M
Loss Per Share	-0.92

Full Income Statement

Balance Sheet

The company has 3.10 billion in cash and 41.09 million in debt, giving a net cash position of 3.06 billion or 13.73 per share.

Cash & Cash Equivalents	3.10B
Total Debt	41.09M
Net Cash	3.06B
Net Cash Per Share	13.73
Equity (Book Value)	3.45B
Book Value Per Share	15.47
Working Capital	2.80B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -516.22 million and capital expenditures -90.33 million, giving a free cash flow of -606.56 million.

Operating Cash Flow	-516.22M
Capital Expenditures	-90.33M
Free Cash Flow	-606.56M
FCF Per Share	-2.72

Full Cash Flow Statement

Margins

Gross margin is 61.98%, with operating and profit margins of -9.78% and -12.40%.

Gross Margin	61.98%
Operating Margin	-9.78%
Pretax Margin	-5.31%
Profit Margin	-12.40%
EBITDA Margin	-7.59%
EBIT Margin	-9.78%
FCF Margin	-30.07%

Dividends & Yields

Sichuan Kelun-Biotech Biopharmaceutical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.62%
Shareholder Yield	-75.62%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sichuan Kelun-Biotech Biopharmaceutical has an Altman Z-Score of 21.16.

Altman Z-Score	21.16
Piotroski F-Score	n/a